Cellectar Biosciences, Inc. Deferred State and Local Income Tax Expense (Benefit)
Cellectar Biosciences, Inc. (CLRB) reported Deferred State and Local Income Tax Expense (Benefit) of -$1.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-04
- Cellectar Biosciences, Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was -$1.61M.
- Cellectar Biosciences, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was -$3.46M.
- Cellectar Biosciences, Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was -$2.76M.
- Cellectar Biosciences, Inc. deferred state and local income tax expense (benefit) for fiscal 2022 was -$2.63M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.61M 10-K · filed 2026-03-04 | |
| 2024-12-31 | -$3.46M 10-K · filed 2026-03-04 | -$3.46M 10-K · filed 2025-03-13 |
| 2023-12-31 | -$2.76M 10-K · filed 2025-03-13 | |
| 2022-12-31 | -$2.63M 10-K/A · filed 2024-10-29 | |
| 2021-12-31 | -$1.07M 10-K · filed 2023-03-09 | |
| 2020-12-31 | -$1.42M 10-K · filed 2022-03-21 | |
| 2019-12-31 | -$6.15M 10-K · filed 2021-03-02 | |
| 2018-12-31 | -$45.14K 10-K · filed 2020-03-09 | |
| 2017-12-31 | $1.97M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $99.88K 10-K · filed 2018-03-21 | |
| 2015-12-31 | $42.56K 10-K · filed 2017-03-15 | |
| 2014-12-31 | $810.91K 10-K/A · filed 2016-10-20 | |
| 2013-12-31 | $134.22K 10-K · filed 2015-05-20 | |
| 2012-12-31 | $2.29M 10-K · filed 2014-03-19 | |
| 2011-12-31 | -$161.96K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |